Project Number 1-I01-BX-004739-01-A2 Agency/Funding Organization United States Department of Veterans Affairs (VA) Funding Year 2020 View Full Project Details for Optimization and preclinical characterization of anthranilamide derivatives for Alzheimer prevention Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator Suo, William (zhiming) Principal Investigator Suo, William (zhiming) Awardee Organization KANSAS CITY VA MEDICAL CENTER Awardee State Missouri Contact PI Country United States Project Detail FY Overall Cost $1,776,630 Funding Organization Agency/Funding Organization United States Department of Veterans Affairs (VA) Funding Organization Country United States
